Chemoradiation: Clinical Trials

9 trials for Chemoradiation, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

5 unknown, 2 completed, 1 active not recruiting, 1 terminated. 9 Phase 2, 2 Phase 1, 2 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 29Unknown 5, Completed 2, Active not recruiting 1, Terminated 1
Phase 12Unknown 2
Phase 32Completed 1, Unknown 1

Follow Chemoradiation: new trials by email Literature Review of Chemoradiation trials Research Report on Chemoradiation

Trials (filtered) newest first · largest first

All 9 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Chemoradiation Plus Tislelizumab for Conversion Therapy of Locally Nonresectable ESCC
Tislelizumab, Paclitaxel, Carboplatin - Esophageal Squamous Cell Carcinoma, Tislelizumab
Phase 1 / Phase 2UnknownJiangsu Cancer Institute & Hospital302022-05-012022-05-27
Testing Ramipril to Prevent Memory Loss in People With Glioblastoma
Ramipril - Glioblastoma, Radiotherapy; Complications
Phase 2CompletedWake Forest University Health Sciences752019-03-252026-03-13
TNT to Increase the Clinical Complete Response Rate for Distal LARC
Capecitabine, Oxaliplatin, External beam radiotherapy, Surgery - Rectal Cancer, Rectal Cancer Stage II
Phase 2Active not recruitingSun Yat-sen University982018-12-252023-10-25
Induction Chemotherapy Plus Chemoradiotherapy With or Without Aspirin in High Risk Rectal Cancer
Aspirin, Placebo Oral Tablet - Rectal Cancer, Adenocarcinoma, Locally Advanced Malignant Neoplasm
Phase 2TerminatedInstituto Nacional de Cancer, Brazil252017-11-302020-12-17
Comparing Paclitaxel/Cisplatin and Cisplatin/5-fluorouracil in Neo-CRT for ESCC
neoadjuvant chemoradiation - Esophageal Squamous Cell Carcinoma, Chemoradiation
Phase 2 / Phase 3UnknownNational Taiwan University Hospital2482017-03-012022-06-07
Phase II/III Study Comparing Chemoradiotherapy With Radiotherapy in Elderly Patients With Esophageal or Esophagogastric Cancer - 3JECROG P-01
SIB-IMRT, S-1 - Esophagus Cancer, Esophagogastric Junction Cancer
Phase 2 / Phase 3CompletedChinese Academy of Medical Sciences3502016-10-012020-07-21
Study of Hypo-fractionated Neoadjuvant Radiotherapy for Locally Advanced Gastric Cancer
Hypo-fractionated radiotherapy, S1 - Gastric Cancer, Chemoradiation
Phase 1 / Phase 2UnknownChinese Academy of Medical Sciences182016-05-012018-02-09
Phase II Study of Neo-adjuvant Chemoradiotherapy for Squamous Cell Esophageal Cancer
radiotherapy, Surgery - Esophageal Cancer, Chemoradiation
Phase 2UnknownShanghai Chest Hospital502016-01-012016-10-19
Definitive Concurrent Chemoradiotherapy With Docetaxel Plus Cisplatin Versus 5-fluorouracil Plus Cisplatin in Patients With Esophageal Squamous Cell Carcinoma
Docetaxel, Fluorouracil - Esophageal Neoplasm, Chemoradiation
Phase 2UnknownZhu Yujia1202010-10-012016-11-21

Narrower conditions

Esophageal Neoplasms (3)  ·  Esophageal Squamous Cell Carcinoma (3)  ·  Rectal Neoplasms (2)  ·  Brain Neoplasms (1)  ·  Cognitive Dysfunction (1)  ·  Glioblastoma (1)  ·  Stomach Neoplasms (1)

Broader conditions

Neoplasms (9)  ·  Neoplasms by Site (9)  ·  Digestive System Diseases (8)  ·  Digestive System Neoplasms (8)  ·  Gastrointestinal Diseases (8)  ·  Gastrointestinal Neoplasms (8)  ·  Esophageal Diseases (5)  ·  Head and Neck Neoplasms (5)  ·  Neoplasms by Histologic Type (4)  ·  Neoplasms, Glandular and Epithelial (4)  ·  Carcinoma (3)  ·  Carcinoma, Squamous Cell (3)  ·  Neoplasms, Squamous Cell (3)  ·  Colorectal Neoplasms (2)  ·  Esophageal Neoplasms (2)

Interventions

Radiotherapy (2)  ·  S 1 (combination) (2)  ·  Surgical Procedures, Operative (2)  ·  Aspirin (1)  ·  Carboplatin (1)  ·  Cisplatin (1)  ·  Docetaxel (1)  ·  Esophagectomy (1)  ·  Fluorouracil (1)  ·  N-hydroxy-4-acetylaminostilbene (1)  ·  Neoadjuvant Therapy (1)  ·  Paclitaxel (1)  ·  Ramipril (1)  ·  XELOX (1)  ·  tislelizumab (1)

Sponsors

Chinese Academy of Medical Sciences (2)  ·  Instituto Nacional de Cancer, Brazil (1)  ·  Jiangsu Cancer Institute & Hospital (1)  ·  National Taiwan University Hospital (1)  ·  Shanghai Chest Hospital (1)  ·  Sun Yat-sen University (1)  ·  Wake Forest University Health Sciences (1)  ·  Zhu Yujia (1)

Countries

China (6)  ·  Brazil (1)  ·  Guam (1)  ·  Taiwan (1)  ·  United States (1)

Top investigators

Glenn Lesser, MD (1)  ·  Luiz Henrique Araujo, MD, PHD (1)  ·  WeiWei Xiao (1)  ·  Xiangzhi Zhu, Dr. (1)  ·  Xiaolong Fu, Ph.D (1)  ·  Yonghong Hu, MD (1)

Results publications

PMID 30089457, PMID 31036088, PMID 32983991, PMID 35219300, PMID 37195667, PMID 37700348, PMID 42318526

NIH funding

3UG1CA189824-04S1 (1)